Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. TFAP2D - Wikipedia
TFAP2D - Wikipedia
From Wikipedia, the free encyclopedia
Mammalian protein found in Homo sapiens
TFAP2D
Identifiers
AliasesTFAP2D, TFAP2BL1, transcription factor AP-2 delta, AP-2delta
External IDsOMIM: 610161; MGI: 2153466; HomoloGene: 17700; GeneCards: TFAP2D; OMA:TFAP2D - orthologs
Gene location (Human)
Chromosome 6 (human)
Chr.Chromosome 6 (human)[1]
Chromosome 6 (human)
Genomic location for TFAP2D
Genomic location for TFAP2D
Band6p12.3Start50,713,526 bp[1]
End50,773,033 bp[1]
Gene location (Mouse)
Chromosome 1 (mouse)
Chr.Chromosome 1 (mouse)[2]
Chromosome 1 (mouse)
Genomic location for TFAP2D
Genomic location for TFAP2D
Band1|1 A3Start19,173,246 bp[2]
End19,236,570 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • oocyte

  • buccal mucosa cell

  • secondary oocyte

  • testicle

  • ganglionic eminence

  • ventral tegmental area

  • amygdala

  • superior frontal gyrus

  • prefrontal cortex

  • dorsolateral prefrontal cortex
Top expressed in
  • urethra

  • female urethra

  • male urethra

  • inferior colliculi

  • myocardium of atrium

  • embryo

  • ganglionic eminence

  • neural layer of retina

  • primordial ventricle

  • lumbar spinal ganglion
More reference expression data
BioGPS
n/a
Gene ontology
Molecular function
  • DNA-binding transcription factor activity
  • DNA binding
  • RNA polymerase II transcription regulatory region sequence-specific DNA binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
Cellular component
  • nucleus
  • transcription regulator complex
Biological process
  • negative regulation of neuron apoptotic process
  • positive regulation of transcription, DNA-templated
  • regulation of transcription, DNA-templated
  • regulation of cell population proliferation
  • inferior colliculus development
  • transcription, DNA-templated
  • positive regulation of transcription by RNA polymerase II
  • anatomical structure development
  • regulation of transcription by RNA polymerase II
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

83741

226896

Ensembl

ENSG00000008197

ENSMUSG00000042596

UniProt

Q7Z6R9

Q91ZK0

RefSeq (mRNA)

NM_172238

NM_153154
NM_001379073
NM_001379074

RefSeq (protein)

NP_758438

NP_694794
NP_001366002
NP_001366003

Location (UCSC)Chr 6: 50.71 – 50.77 MbChr 1: 19.17 – 19.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Transcription factor AP-2 delta (activating enhancer binding protein 2 delta), also known as TFAP2D, is a human gene. The protein encoded by this gene is a transcription factor.[5]

See also

[edit]
  • Activating protein 2

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000008197 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000042596 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Cheng C, Ying K, Xu M, Zhao W, Zhou Z, Huang Y, Wang W, Xu J, Zeng L, Xie Y, Mao Y (January 2002). "Cloning and characterization of a novel human transcription factor AP-2 beta like gene (TFAP2BL1)". Int. J. Biochem. Cell Biol. 34 (1): 78–86. doi:10.1016/S1357-2725(01)00098-X. PMID 11733187.

External links

[edit]
  • TFAP2D+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • v
  • t
  • e
Transcription factors and intracellular receptors
(1) Basic domains
(1.1) Basic leucine zipper (bZIP)
  • Activating transcription factor
    • AATF
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • AP-1
    • c-Fos
    • FOSB
    • FOSL1
    • FOSL2
    • JDP2
    • c-Jun
    • JUNB
    • JunD
  • BACH
    • 1
    • 2
  • BATF
  • BLZF1
  • C/EBP
    • α
    • β
    • γ
    • δ
    • ε
    • ζ
  • CREB
    • 1
    • 3
    • L1
  • CREM
  • DBP
  • DDIT3
  • GABPA
  • GCN4
  • HLF
  • MAF
    • B
    • sMaf
      • F
      • G
      • K
  • NFE
    • 2
    • L1
    • L2
    • L3
  • NFIL3
  • NRL
  • NRF
    • 1
    • 2
    • 3
  • XBP1
(1.2) Basic helix-loop-helix (bHLH)
Group A
  • AS-C
    • ASCL1
    • ASCL2
  • ATOH1
  • HAND
    • 1
    • 2
  • MESP2
  • Myogenic regulatory factors
    • MyoD
    • Myogenin
    • MYF5
    • MYF6
  • NeuroD
    • 1
    • 2
  • Neurogenins
    • 1
    • 2
    • 3
  • OLIG
    • 1
    • 2
  • Paraxis
    • TCF15
    • Scleraxis
  • SLC
    • LYL1
    • TAL
      • 1
      • 2
  • Twist
Group B
  • FIGLA
  • Myc
    • c-Myc
    • l-Myc
    • n-Myc
  • MXD4
  • TCF4
Group C
bHLH-PAS
  • AhR
  • AHRR
  • ARNT
    • ARNTL
    • ARNTL2
  • CLOCK
  • HIF
    • 1A
    • EPAS1
    • 3A
  • NPAS
    • 1
    • 2
    • 3
  • PER
    • 1
    • 2
    • 3
    • Period
  • SIM
    • 1
    • 2
Group D
  • DEC
    • 1
    • 2
  • BHLHA9
  • Pho4
  • ID
    • 1
    • 2
    • 3
    • 4
Group E
  • HES
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • HEY
    • 1
    • 2
    • L
Group F
bHLH-COE
  • EBF1
(1.3) bHLH-ZIP
  • AP-4
  • MAX
    • MXD1
    • MXD3
  • MITF
  • MNT
  • MLX
  • MLXIPL
  • MXI1
  • Myc
  • SREBP
    • 1
    • 2
  • USF1
(1.4) NF-1
  • NFI
    • A
    • B
    • C
    • X
  • SMAD
    • R-SMAD
      • 1
      • 2
      • 3
      • 5
      • 9
    • I-SMAD
      • 6
      • 7
    • 4)
(1.5) RF-X
  • RFX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • ANK
(1.6) Basic helix-span-helix (bHSH)
  • AP-2
    • α
    • β
    • γ
    • δ
    • ε
(2) Zinc finger DNA-binding domains
(2.1) Nuclear receptor (Cys4)
subfamily 1
  • Thyroid hormone
    • α
    • β
  • CAR
  • FXR
  • LXR
    • α
    • β
  • PPAR
    • α
    • β/δ
    • γ
  • PXR
  • RAR
    • α
    • β
    • γ
  • ROR
    • α
    • β
    • γ
  • Rev-ErbA
    • α
    • β
  • VDR
subfamily 2
  • COUP-TF
    • (I
    • II
  • Ear-2
  • HNF4
    • α
    • γ
  • PNR
  • RXR
    • α
    • β
    • γ
  • Testicular receptor
    • 2
    • 4
  • TLX
subfamily 3
  • Steroid hormone
    • Androgen
    • Estrogen
      • α
      • β
    • Glucocorticoid
    • Mineralocorticoid
    • Progesterone
  • Estrogen related
    • α
    • β
    • γ
subfamily 4
  • NUR
    • NGFIB
    • NOR1
    • NURR1
subfamily 5
  • LRH-1
  • SF1
subfamily 6
  • GCNF
subfamily 0
  • DAX1
  • SHP
(2.2) Other Cys4
  • GATA
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • MTA
    • 1
    • 2
    • 3
  • TRPS1
(2.3) Cys2His2
  • General transcription factors
    • TFIIA
    • TFIIB
    • TFIID
    • TFIIE
      • 1
      • 2
    • TFIIF
    • 1
    • 2
      • TFIIH
      • 1
      • 2
      • 4
      • 2I
      • 3A
      • 3C1
      • 3C2
  • ATBF1
  • BCL
    • 6
    • 11A
    • 11B
  • CTCF
  • E4F1
  • EGR
    • 1
    • 2
    • 3
    • 4
  • ERV3
  • GFI1
  • GLI family
    • 1
    • 2
    • 3
    • REST
    • S1
    • S2
    • YY1
  • HIC
    • 1
    • 2
  • HIVEP
    • 1
    • 2
    • 3
  • IKZF
    • 1
    • 2
    • 3
  • ILF
    • 2
    • 3
  • Sp/KLF family
    • KLF
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      • 13
      • 14
      • 15
      • 17
    • SP
      • 1
      • 2
      • 4
      • 7
      • 8
  • MTF1
  • MYT1
  • OSR1
  • PRDM9
  • SALL
    • 1
    • 2
    • 3
    • 4
  • TSHZ3
  • WT1
  • Zbtb7
    • 7A
    • 7B
  • ZBTB
    • 11
    • 16
    • 17
    • 20
    • 21
    • 32
    • 33
    • 40
  • zinc finger
    • 3
    • 7
    • 9
    • 10
    • 19
    • 22
    • 24
    • 33B
    • 34
    • 35
    • 41
    • 43
    • 44
    • 51
    • 74
    • 143
    • 146
    • 148
    • 165
    • 202
    • 217
    • 219
    • 238
    • 239
    • 259
    • 267
    • 268
    • 281
    • 300
    • 318
    • 330
    • 346
    • 350
    • 365
    • 366
    • 384
    • 423
    • 451
    • 452
    • 471
    • 593
    • 638
    • 644
    • 649
    • 655
    • 804A
(2.4) Cys6
  • HIVEP1
(2.5) Alternating composition
  • AIRE
  • DIDO1
  • GRLF1
  • ING
    • 1
    • 2
    • 4
  • JARID
    • 1A
    • 1B
    • 1C
    • 1D
    • 2
  • JMJD1B
(2.6) WRKY
  • WRKY
(3) Helix-turn-helix domains
(3.1) Homeodomain
Antennapedia
ANTP class
protoHOX
Hox-like
  • ParaHox
    • Gsx
      • 1
      • 2
    • Xlox
      • PDX1
    • Cdx
      • 1
      • 2
      • 4
  • extended Hox: Evx1
  • Evx2
  • MEOX1
  • MEOX2
  • Homeobox
    • A1
    • A2
    • A3
    • A4
    • A5
    • A7
    • A9
    • A10
    • A11
    • A13
    • B1
    • B2
    • B3
    • B4
    • B5
    • B6
    • B7
    • B8
    • B9
    • B13
    • C4
    • C5
    • C6
    • C8
    • C9
    • C10
    • C11
    • C12
    • C13
    • D1
    • D3
    • D4
    • D8
    • D9
    • D10
    • D11
    • D12
    • D13
  • GBX1
  • GBX2
  • MNX1
metaHOX
NK-like
  • BARHL1
  • BARHL2
  • BARX1
  • BARX2
  • BSX
  • DBX
    • 1
    • 2
  • DLX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • EMX
    • 1
    • 2
  • EN
    • 1
    • 2
  • HHEX
  • HLX
  • LBX1
  • LBX2
  • MSX
    • 1
    • 2
  • NANOG
  • NKX
    • 2-1
    • 2-2
    • 2-3
    • 2-5
    • 3-1
    • 3-2
    • HMX1
    • HMX2
    • HMX3
    • 6-1
    • 6-2
  • NOTO
  • TLX1
  • TLX2
  • TLX3
  • VAX1
  • VAX2
other
  • ARX
  • CRX
  • CUTL1
  • FHL
    • 1
    • 2
    • 3
  • HESX1
  • HOPX
  • LMX
    • 1A
    • 1B
  • NOBOX
  • TALE
    • IRX
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • MKX
    • MEIS
      • 1
      • 2
    • PBX
      • 1
      • 2
      • 3
    • PKNOX
      • 1
      • 2
    • SIX
      • 1
      • 2
      • 3
      • 4
      • 5
  • PHF
    • 1
    • 3
    • 6
    • 8
    • 10
    • 16
    • 17
    • 20
    • 21A
  • POU domain
    • PIT-1
    • BRN-3: A
    • B
    • C
    • Octamer transcription factor: 1
    • 2
    • 3/4
    • 6
    • 7
    • 11
  • SATB2
  • ZEB
    • 1
    • 2
(3.2) Paired box
  • PAX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
  • PRRX
    • 1
    • 2
  • PROP1
  • PHOX
    • 2A
    • 2B
  • RAX
  • SHOX
  • SHOX2
  • VSX1
  • VSX2
  • Bicoid
    • GSC
    • BICD2
    • OTX
      • 1
      • 2
    • PITX
      • 1
      • 2
      • 3
(3.3) Fork head / winged helix
  • E2F
    • 1
    • 2
    • 3
    • 4
    • 5
  • FOX proteins
    • A1
    • A2
    • A3
    • B1
    • B2
    • C1
    • C2
    • D1
    • D2
    • D3
    • D4
    • D4L1
    • D4L3
    • D4L4
    • D4L5
    • D4L6
    • E1
    • E3
    • F1
    • F2
    • G1
    • H1
    • I1
    • I2
    • I3
    • J1
    • J2
    • J3
    • K1
    • K2
    • L1
    • L2
    • M1
    • N1
    • N2
    • N3
    • N4
    • O1
    • O3
    • O4
    • O6
    • P1
    • P2
    • P3
    • P4
    • Q1
    • R1
    • R2
    • S1
(3.4) Heat shock factors
  • HSF
    • 1
    • 2
    • 4
(3.5) Tryptophan clusters
  • ELF
    • 2
    • 4
    • 5
  • EHF
  • ELK
    • 1
    • 3
    • 4
  • ERF
  • ETS
    • 1
    • 2
    • ERG
    • SPIB
  • ETV
    • 1
    • 4
    • 5
    • 6
  • FLI1
  • Interferon regulatory factors
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
  • MYB
  • MYBL2
(3.6) TEA domain
  • transcriptional enhancer factor
    • 1
    • 2
    • 3
    • 4
(4) β-Scaffold factors with minor groove contacts
(4.1) Rel homology region
  • NF-κB
    • NFKB1
    • NFKB2
    • REL
    • RELA
    • RELB
  • NFAT
    • C1
    • C2
    • C3
    • C4
    • 5
(4.2) STAT
  • STAT
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
(4.3) p53-like
  • p53 p63 p73 family
    • p53
    • TP63
    • p73
  • TBX
    • 1
    • 2
    • 3
    • 5
    • 19
    • 21
    • 22
    • TBR1
    • TBR2
    • TFT
  • MYRF
(4.4) MADS box
  • Mef2
    • A
    • B
    • C
    • D
  • SRF
(4.6) TATA-binding proteins
  • TBP
  • TBPL1
(4.7) High-mobility group
  • BBX
  • HMGB
    • 1
    • 2
    • 3
    • 4
  • HMGN
    • 1
    • 2
    • 3
    • 4
  • HNF
    • 1A
    • 1B
  • SOX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 17
    • 18
    • 21
  • SRY
  • SSRP1
  • TCF/LEF
    • TCF
      • 1
      • 3
      • 4
    • LEF1
  • TOX
    • 1
    • 2
    • 3
    • 4
(4.9) Grainyhead
  • TFCP2
(4.10) Cold-shock domain
  • CSDA
  • YBX1
(4.11) Runt
  • CBF
    • CBFA2T2
    • CBFA2T3
    • RUNX1
    • RUNX2
    • RUNX3
    • RUNX1T1
(0) Other transcription factors
(0.2) HMGI(Y)
  • HMGA
    • 1
    • 2
  • HBP1
(0.3) Pocket domain
  • Rb
  • RBL1
  • RBL2
(0.5) AP-2/EREBP-related factors
  • Apetala 2
  • EREBP
  • B3
(0.6) Miscellaneous
  • ARID
    • 1A
    • 1B
    • 2
    • 3A
    • 3B
    • 4A
  • CAP
  • IFI
    • 16
    • 35
  • MLL
    • 2
    • 3
    • T1
  • MNDA
  • NFY
    • A
    • B
    • C
  • Rho/Sigma
see also transcription factor/coregulator deficiencies


Stub icon

This article on a gene on human chromosome 6 is a stub. You can help Wikipedia by adding missing information.

  • v
  • t
  • e
Retrieved from "https://teknopedia.ac.id/w/index.php?title=TFAP2D&oldid=1132434929"
Categories:
  • Genes on human chromosome 6
  • Transcription factors
  • Human chromosome 6 gene stubs
Hidden categories:
  • Articles with short description
  • Short description matches Wikidata
  • All stub articles

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id